Leukemia & Lymphoma Biobank

In 2016, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Altnata and Emory University have partnered together to establish a Leukemia & Lymphoma Biobank for the department of pediatrics. The biobank has expanded and continues to collect and house human biological specimens.

These specimens are an invaluable resource necessary for the acceleration of translational cancer research. The biobank gives principal investigators the capability to test the validity as well as reproducibility of laboratory findings via experimentation with patient bone marrow and peripheral blood samples.

Advancing a cure for cancer has been slow due to the nature of tumors. Tumors are a haven for a variety of mutational aberrations in genes. In fact there are so many variations that its clear that each individual patient is unique and requires a specialized therapy for optimal recovery. Thus it is critical to offer medical doctors an all-encompassing  database with genomic and molecular data for a large patient population cohort. This will allow for a comparison and analysis of the genetic profile and molecular markers of a subset of a population and thereby lead to more informed and targeted therapies for each patient.